AVEO Oncology
AVEO
#7039
Rank
C$0.70 B
Marketcap
C$20.37
Share price
0.00%
Change (1 day)
155.91%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -C$37.21 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are C$94.31 Million. In 2021 the company made an earning of -C$72.45 Million a decrease over its 2020 earnings that were of -C$48.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -C$37.21 Million-48.65%
2021 -C$72.45 Million49.9%
2020 -C$48.33 Million-479.04%
2019 C$12.75 M-276.17%
2018 -C$7.24 Million-91.79%
2017 -C$88.18 Million142.38%
2016 -C$36.39 Million78.51%
2015 -C$20.38 Million-71.55%
2014 -C$71.63 Million-50.72%
2013 -C$0.15 Billion-4.88%
2012 -C$0.16 Billion-426.29%
2011 C$46.83 M-159.85%
2010 -C$78.27 Million35.33%
2009 -C$57.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
C$30.56 B-77,594.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.19 B-28,489.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.58 B-6,656.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$7.10 B-18,112.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$10.91 B-27,762.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-C$3.07 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA